Mirae Asset Global ETFs Holdings’s IGM Biosciences IGMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,096
Closed -$10.5K 3111
2025
Q1
$10.5K Buy
9,096
+390
+4% +$725 ﹤0.01% 3020
2024
Q4
$53.2K Buy
8,706
+380
+5% +$4.51K ﹤0.01% 2889
2024
Q3
$138K Buy
8,326
+1,818
+28% +$19.9K ﹤0.01% 2554
2024
Q2
$44.7K Buy
+6,508
New +$55.7K ﹤0.01% 2814

Other funds holding IGMS

Mirae Asset Global ETFs Holdings's IGMS Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of IGM Biosciences (IGMS) in Q2 2025, closing a stake of 9,096 shares — an estimated $10.5K sold.

Mirae Asset Global ETFs Holdings first reported a position in IGMS in Q2 2024 and held it in 4 quarters. The position peaked at $138K in Q3 2024. 66 funds tracked by Wall St. Rank hold IGMS as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining IGM Biosciences position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 9,096 IGM Biosciences shares in Q2 2025, an estimated $10.5K.
  • Mirae Asset Global ETFs Holdings first reported a position in IGM Biosciences in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's IGM Biosciences position peaked at $138K in Q3 2024.
  • 66 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.